Details

Autor(en) / Beteiligte

• Özen, Seza
• Batu, Ezgi Deniz
• Taşkıran, Ekim Z
• Özkara, Hatice Asuman
• Ünal, Şule
• Güleray, Naz
• Erden, Abdulsamet
• Karadağ, Ömer
• Gümrük, Fatma
• Çetin, Mualla
• Sönmez, Hafize Emine
• Bilginer, Yelda
• Ayvaz, Deniz Çağdaş
• Tezcan, Ilhan

Titel

A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2

Ist Teil von

• Journal of rheumatology, 2020-01, Vol.47 (1), p.117

Ort / Verlag

Canada

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disorder associated with mutations. We aimed to investigate the characteristics and ADA2 enzyme activities of patients with DADA2 compared to non-DADA2 patients. This is a descriptive study of 24 patients with DADA2 who were admitted to the Adult and Pediatric Rheumatology, Pediatric Haematology, and Pediatric Immunology Departments of Hacettepe University. All exons were screened by Sanger sequencing. Serum ADA2 enzyme activity was measured by modified spectrophotometric method. Twenty-four patients with DADA2 were included: 14 with polyarteritis nodosa (PAN)-like phenotype (Group 1); 9 with Diamond-Blackfan anemia (DBA)-like features, and 1 with immunodeficiency (Group 2). Fourteen PAN-like DADA2 patients did not have the typical thrombocytosis seen in classic PAN. Inflammatory attacks were evident only in Group 1 patients. Serum ADA2 activity was low in all patients with DADA2 except one, who was tested after hematopoietic stem cell transplantation. There was no significant difference in ADA2 activities between PAN-like and DBA-like patients. In DADA2 patients with one mutation, serum ADA2 activities were as low as those of patients with homozygote DADA2. ADA2 activities were normal in non-DADA2 patients. mutations were affecting the dimerization domain in Group 1 patients and the catalytic domain in Group 2 patients. We suggest assessing ADA2 activity along with genetic analysis because there are patients with one mutation and absent enzyme activity. Our data suggest a possible genotype-phenotype correlation in which dimerization domain mutations are associated with PAN-like phenotype, and catalytic domain mutations are associated with hematological manifestations.